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Abstract 
Nicotine is a stimulatory component in tobacco and induces psychological dependence 
through its rewarding effect in the central nervous system (CNS), thereby leading to the nicotine 
addiction. The therapeutics of nicotine dependence to improve nicotine addiction and  quality 
of life have not been established. We first found that curcuminoid, anti-inflammatory agent 
prevents both nicotine dependence and relapse when mice were assessed by the conditioned 
placed preference (CPP) test. Curcuminoid (1, 3.2, and 10 mg·kg-1, oral) dose-dependently 
inhibited development of nicotine dependence when it was administrated 30 minutes prior to 
nicotine administration (0.5 mg·kg-1, i.p.) for consecutive 7 days. In addition, curcuminoid 
significantly suppressed the priming effects of nicotine, in which inhibition of 
acetylcholinesterase activity is associated. However, further extensive studies are required to 
define the inhibitory mechanism of acetylcholinesterase activity by curcuminoid.  
We performed CPP test for 28 days administration of nicotine to establish the nicotine-
induced CPP as representative of nicotine reward and reinforcement. Since dopamine mediates 
nicotine dependence through the nucleus accumbens and hippocampus, we assessed 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated 
kinase (ERK) signals.   
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We first found that, in addition to D1R antagonist (SCH23390), D2R antagonist 
(eticlopride) administration with 30 minutes prior to nicotine administration completely 
abolishes the nicotine dependence in both 2 and 4 weeks nicotine conditioning mice as shown 
in figure. Although the involvement of dopamine D1 receptor (D1R) has been well documented 
in the nicotine dependence, however, the role of D2R remains unclear. Thus, we investigated 
whether D2R is critical for nicotine dependence behaviors using D2R knock out (D2RKO) mice. 
We first assessed the nicotine-induced CPP behaviors in wild type (WT) and D2RKO mice. 
D2RKO mice were then subjected to neurochemical analyses after nicotine-conditioning with 
CPP. Interestingly, D2RKO mice failed to develop the nicotine-induced CPP behaviors after 
continuous nicotine administration with 0.5 mg/kg for 4 weeks as shown in figure. 





































































































Since both nucleus accumbens and hippocamus have central role in the nicotine-induced 
CPP behaviors, we investigated both CaMKII and ERK signaling both in the nucleus accumbens 
and hippocampal CA1 region after 4 weeks administration of nicotine. Notably, both CaMKII 
and ERK phosphorylation in both regions were elevated by nicotine administration in WT mice. 
However, these kinase pathways were unchanged in D2RKO mice. Moreover, the basal levels 
of CaMKII and ERK phosphorylation were significantly reduced in D2RKO mice. Consistent 
with immunoblotting results, immunostaining analyses showed the number of phosphorylated 
CaMKII and ERK positive cells in nucleus accumbens elevated on WT mice but not in D2KO 
mice after nicotine treatment for 4 weeks administration. 
The nicotine-induced CPP behaviors were associated with elevation of Pro-BDNF and 
BDNF protein levels in WT mice. On the other hand, Pro-BDNF and BDNF protein levels were 
unchanged after chronic nicotine administration for 28 consecitive days in D2RKO mice. Taken 
together we propose the possible mechanism how the dopamine D2R pathway generates 
nicotine-induced CPP behaviors.  Nicotine administration activates α4β2nAChRs and 
α7nAChRs in the dopaminergic terminals as shown in figure. Nicotine administration enhances 
DA release by stimulation of both nAChRs. The released DA stimulates D2R thereby enhancing 
MEK and ERK1/2 pathway through enhancement of cytosolic tyrosine kinase and in turn 
causes CREB phosphorylation in nucleus accumbens. Additionally, D2R activation elevates 
CaMKII signaling by elevation of intracellular calcium. The CaMKII activation also mediates 
CREB phosphorylation followed by pro-BDNF production. The pro-BDNF is degraded by 
proteolytic enzyme to produce mature BDNF. BDNF may be essential for synaptic 
rearrangement accounting for nicotine-induced CPP behavior. As shown previously, D1R 
stimulation also mediates BDNF expression through cyclic AMP-dependent protein kinase 
(PKA) pathway in the different neurons from D2R expressing neurons. 
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In conclusion, activation of CaMKII and ERK1/2 through D2R are associated with nicotine-
induced CPP behavior. Like D1R, D2R is critical for nicotine-induced CPP behavior. We also 
propose curcuminoid as therapeutic candidate to ameliorate nicotine dependence and relapse.  
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存形成にドパミン D2 受容体が関与することを D2 受容体欠損マウスで証明した。これまで
にも D1 受容体が cAMP 系を介してニコチン依存形成に関わることが報告されているが、
D2 受容体の役割については不明である。本研究では D2 受容体欠損マウスでニコチン依存
が形成されないこと、ニコチン依存形成には脳内でのカルシウム依存性プロテインキナー
ゼの活性化とその活性化による神経栄養因子（BNDF）の誘導が重要であることを明らかに
した。さらに、ニコチン依存形成に重要な側座核において D2 受容体欠損マウスでは D1 受
容体の機能も低下することを明らかにした。以上のことから、ニコチン依存形成を抑制す
る治療薬開発には D2 受容体を標的にすることが重要であること示した。 
 以上、本研究ではニコチン依存性形成におけるドパミン D2 受容体の重要な役割を明らか
にした。さらに、食品にも使われるクルクミン類がニコチン依存形成を抑制することを明
らかにした。今後は、クルクミン類の効能についてヒトでの検討が必要である。Wilar 氏の
母国であるインドネシアでは少年期からのタバコ汚染が社会問題となっている。タバコ喫
煙による依存症、生活習慣病を予防するためにも本研究が貢献することが期待できる。 
 よって、本論文は博士（薬科学）の学位論文として合格と認める。 
